Log in to your Inderes Free account to see all free content on this page.
Cinclus Pharma
17.72 SEK
+2.55 %
Less than 1K followers
CINPHA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cinclus Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.6 | 4.6 | 34.1 | 9.7 | 13.6 | 57.5 | ||
| EBITDA | -39.2 | -56.6 | -168.3 | -47.1 | -45.5 | -43.4 | ||
| EBIT | -39.2 | -56.9 | -169.6 | -47.5 | -45.9 | -44.1 | -62.0 | -199.6 |
| EBIT-% | -1,242.1 % | -3,703.9 % | -134.6 % | -453.0 % | -454.9 % | -347.2 % | ||
| Profit before taxes | -36.4 | -54.1 | -167.3 | -33.6 | -48.3 | -40.6 | -61.1 | -183.7 |
| Net income | -36.6 | -54.3 | -168.0 | -33.7 | -48.5 | -40.7 | -61.2 | -184.0 |
Login required
This content is only available for logged in users